Science · 1988 · 1.2K citations · 15 references
Life SciencesNeurosciencePharmacologyMolecular PharmacologyNeurochemistryNeuropharmacologyGlutamatergic PharmacologyNeurotransmissionNeurotransmitter ReceptorsNeurotransmitter SystemsReceptor PharmacologySynaptic TransmissionAntagonist PotencyCompetitive Antagonism At Glutamate ReceptorsGlutamate Receptor AntagonismKainate ReceptorsN-methyl-d-aspartate Receptor AntagonismNmda Receptor AntagonismNmda Receptor AntagonistsNmda Receptors
The N-methyl-D-aspartate (NMDA)-subtype of glutamate receptors has been well described as a result of the early appearance of NMDA antagonists, but no potent antagonist for the "non-NMDA" glutamate receptors has been available. Quinoxalinediones have now been found to be potent and competitive antagonists at non-NMDA glutamate receptors. These compounds will be useful in the determination of the structure-activity relations of quisqualate and kainate receptors and the role of such receptors in synaptic transmission in the mammalian brain.
15
Nabil A. Anis, Stephen C. Berry, N.R. Burton et al. · British Journal of Pharmacology · 1983 · 1.4K citations · Full text
Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites
Daniel T. Monaghan, Vicky R. Holets, Darryl W. Toy et al. · Nature · 1983 · 525 citations
J. Timothy Greenamyre, James M. Olson, John B. Penney et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 370 citations